Ho Chi Minh City recently welcomed 200 Iranian tourists on the inaugural direct charter flight from Tehran, marking a ...
A researcher described as a pioneering force for women's health in Aotearoa has been named Kiwibank New Zealander of the Year ...
Biography: Soorya Chandar is an Indian film artist, who has worked predominantly in the Tamil movie industry.
Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy. But new ...
The Print on MSN1 天
The real Bihar godfather is the land mafia. Fake receipts, muscle power, kangaroo courtsThe absence of an alternate big urban centre has led to the over congestion of Patna, skyrocketing land prices in a state ...
Glioblastoma has long resisted treatment, but scientists may have found a breakthrough by leveraging the body's own ...
News-Medical.Net on MSN2 天
New research reveals potential path forward for glioblastoma treatmentGlioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy.
Company has reported net profit after tax of Rs 8,420.23 Crore in latest quarter.The company’s top management includes Mr.P M Prasad, Mr.P M Prasad, Mr.Nagaraju Maddirala, Mrs.Nirupama Kotru, Dr.Arun ...
尽管胶质母细胞瘤的发病率很高，但其治疗效果在过去20年内几乎没有改善。由于这种疾病具有强烈的免疫抑制微环境，不同患者的表现千差万别，且手术条件也极具挑战性，因此治疗起来仍然非常困难。 资深作者、西尔维斯特综合癌症中心的神经外科医生兼研究员Ashish H. Shah博士称：“脑肿瘤是医学领域中最可怕的敌人之一。我们目前的治疗方案远远不够。” ...
胶质母细胞瘤一直是治疗难度最高的癌症之一，即使面对最新的免疫疗法进展也毫无畏惧。然而，迈阿密大学米勒医学院的西尔维斯特综合癌症中心的一项新研究指出了一条前进的道路：抑制一种名为ZNF638的蛋白可以触发抗病毒免疫反应，从而增强免疫检查点抑制剂的效果。这一发现不仅提供了一种潜在的新治疗策略，还确定了ZNF638作为一种生物标志物，有助于为患者个性化免疫治疗。相关研究结果发表在3月17日的《Journ ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈